TITLE

Identification of Novel AR-Targeted MicroRNAs Mediating Androgen Signalling through Critical Pathways to Regulate Cell Viability in Prostate Cancer

AUTHOR(S)
Mo, Wenjuan; Zhang, Jiyuan; Li, Xia; Meng, Delong; Gao, Yun; Yang, Shu; Wan, Xuechao; Zhou, Caihong; Guo, Fenghua; Huang, Yan; Amente, Stefano; Avvedimento, Enrico V.; Xie, Yi; Li, Yao
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
MicroRNAs (miRNAs) have been recognized as significantly involved in prostate cancer (PCa). Since androgen receptor (AR) plays a central role in PCa carcinogenesis and progression, it is imperative to systematically elucidate the causal association between AR and miRNAs, focusing on the molecular mechanisms by which miRNAs mediate AR signalling. In this study, we performed a series of time-course microarrays to observe the dynamic genome-wide expressions of mRNAs and miRNAs in parallel in hormone-sensitive prostate cancer LNCaP cells stimulated by androgen. Accordingly, we introduced Response Score to identify AR target miRNAs, as well as Modulation Score to identify miRNA target mRNAs. Based on theoretical identification and experimental validation, novel mechanisms addressing cell viability in PCa were unravelled for 3 miRNAs newly recognized as AR targets. (1) miR-19a is directly up-regulated by AR, and represses SUZ12, RAB13, SC4MOL, PSAP and ABCA1, respectively. (2) miR-27a is directly up-regulated by AR, and represses ABCA1 and PDS5B. (3) miR-133b is directly up-regulated by AR, and represses CDC2L5, PTPRK, RB1CC1, and CPNE3, respectively. Moreover, we found miR-133b is essential to PCa cell survival. Our study gives certain clues on miRNAs mediated AR signalling to cell viability by influencing critical pathways, especially by breaking through androgen’s growth restriction effect on normal prostate tissue.
ACCESSION #
87624751

 

Related Articles

  • PEpiD: A Prostate Epigenetic Database in Mammals Shi, Jiejun; Hu, Jian; Zhou, Qing; Du, Yanhua; Jiang, Cizhong // PLoS ONE;May2013, Vol. 8 Issue 5, p1 

    Epigenetic mechanisms play key roles in initiation and progression of prostate cancer by changing gene expression. The Prostate Epigenetic Database (PEpiD: http://wukong.tongji.edu.cn/pepid) archives the three extensively characterized epigenetic mechanisms DNA methylation, histone modification,...

  • MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance. Ottman, Richard; Nguyen, Camha; Lorch, Robert; Chakrabarti, Ratna // Molecular Cancer;2014, Vol. 13 Issue 1, p1 

    Background Development of resistance to androgen deprivation therapy (ADT) is a major obstacle for the management of advanced prostate cancer. Therapies with androgen receptor (AR) antagonists and androgen withdrawal initially regress tumors but development of compensatory mechanisms including...

  • MicroRNAs in an Oral Cancer Context – from Basic Biology to Clinical Utility. Gorenchtein, M.; Poh, C.F.; Saini, R.; Garnis, C. // Journal of Dental Research;May2012, Vol. 91 Issue 5, p440 

    Oral cancer is one of the most commonly diagnosed malignancies worldwide. Its dismal five-year survival rate of ~50% has barely changed for decades. A better understanding of the molecular basis of tumorigenesis – with particular emphasis on disease initiation and progression – is...

  • Pathogenesis of prostate cancer and hormone refractory prostate cancer. Girling, J. S.; Whitaker, H. C.; Mills, I. G.; Neal, D. E. // Indian Journal of Urology;Jan-Mar2007, Vol. 23 Issue 1, p35 

    Prostate cancer is the second most common malignancy in males and the leading cause of cancer death. Prostate cancer is initially androgen dependent and relies upon the androgen receptor (AR) to mediate the effects of androgens. The AR is also the target for therapy using antiandrogens and LHRH...

  • MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth. Nadiminty, Nagalakshmi; Tummala, Ramakumar; Wei Lou; Yezi Zhu; Xu-Bao Shi; Zou, June X.; Chen, Hongwu; Jin Zhang; Xinbin Chen; Jun Luo; deVere White, Ralph W.; Kung, Hsing-Jien; Evans, Christopher P.; Gao, Allen C. // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Purpose: Prostate cancer (PCa) is characterized by deregulated expression of several tumor suppressor or oncogenic miRNAs. The objective of this study was the identification and characterization of miR-let-7c as a potential tumor suppressor in PCa. Experimental Design: Levels of expression of...

  • MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth. Nadiminty, Nagalakshmi; Tummala, Ramakumar; Wei Lou; Yezi Zhu; Xu-Bao Shi; Zou, June X.; Chen, Hongwu; Jin Zhang; Xinbin Chen; Jun Luo; deVere White, Ralph W.; Kung, Hsing-Jien; Evans, Christopher P.; Gao, Allen C. // PLoS ONE;Mar2012, Vol. 7 Issue 3, p1 

    Purpose: Prostate cancer (PCa) is characterized by deregulated expression of several tumor suppressor or oncogenic miRNAs. The objective of this study was the identification and characterization of miR-let-7c as a potential tumor suppressor in PCa. Experimental Design: Levels of expression of...

  • HIV Tat Induces Expression of ICAM-1 in HUVECs: Implications for miR-221/-222 in HIV-Associated Cardiomyopathy. Duan, Ming; Yao, Honghong; Hu, Guoku; Chen, XianMing; Lund, Amie K.; Buch, Shilpa // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Cardiac involvement is a well-documented complication of human immunodeficiency virus-1 (HIV-1) infection. Previous studies have demonstrated increased adhesion of monocytes to human vascular endothelial cells in HIV-infected individuals. HIV Tat protein, which is the transactivator of...

  • ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype. Smith, A.M.; Findlay, V.J.; Bandurraga, S.G.; Kistner-Griffin, E.; Spruill, L.S.; Liu, A.; Golshayan, A.R.; Turner, D.P. // Carcinogenesis;Mar2012, Vol. 33 Issue 3, p572 

    Advanced disease accounts for the majority of prostate cancer-related deaths and androgen deprivation therapy (ADT) is the standard of care for these patients. Many patients undergoing ADT become resistant to its effects and progress to castrate-resistant prostate cancer (CRPC). Current...

  • Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer. Lallous, Nada; Dalal, Kush; Cherkasov, Artem; Rennie, Paul S. // International Journal of Molecular Sciences;Jun2013, Vol. 14 Issue 6, p12496 

    Recurrent, metastatic prostate cancer continues to be a leading cause of cancer-death in men. The androgen receptor (AR) is a modular, ligand-inducible transcription factor that regulates the expression of genes that can drive the progression of this disease, and as a consequence, this receptor...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics